Moreover, they ameliorate synaptic transmission deficits mainly through the upregulation of ACh PKC, NR2B, and CaMKII expression and downregulation of AChE expression in the hippocampus in the early and late phases of AD in animal models (Table 5 and Figure 5). This evidence concerns the gene ACHE and Alzheimer disease.